MY CLINIC
The cost of stem cell therapy for neuropathy in Czechia typically ranges from $12,000. Pricing can vary depending on the clinic, the experience of the medical team, and the specific type and quantity of stem cells used. In the United States, the average cost is $25,000 (per AAOS). This means stem cell therapy for neuropathy in Czechia is about 52% less than in the U.S.
Czech clinics usually include the initial consultation, pre-operative blood tests, post-operative medication, follow-up consultations, personalized treatment plans, English-speaking staff, post-op care instructions, meals during clinic visits, and 24/7 patient support. In the U.S., many of these services are billed separately, with listed prices often covering only the procedure itself. Always confirm exactly what’s included with each clinic.
Why choose the Czech Republic for stem cell therapy for neuropathy?
Access advanced Stem cell therapy for neuropathy solutions in trusted clinics from $12,000.
| Czech Republic | Turkey | Austria | |
| Stem cell therapy for neuropathy | from $12,000 | from $7,000 | ≈ $5,500 |
No hidden fees – just official clinic prices. Pay at the clinic for Stem cell therapy for neuropathy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Stem cell therapy for neuropathy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Stem cell therapy for neuropathy journey.
Stem cell therapy for neuropathy is not a standard medical treatment in the Czech Republic. While legal for specific hematological conditions, its use for neuropathy remains restricted to experimental trials. The State Institute for Drug Control (SÚKL) strictly regulates cell applications according to European Union safety directives.
Bookimed Expert Insight: While basic stem cell therapy starts at $10,600, neuropathy-specific protocols range from $12,000. Patients often overlook that public insurance like VZP never covers these experimental costs. Choosing a clinic like MY CLINIC, which partners with Charles University, helps ensure higher academic and safety oversight.
Patient Consensus: Patients treat this therapy as experimental rather than a guaranteed cure. Many find better symptom relief by combining medical advice with vitamin B12 and specific foot exercises.
Stem cell therapy for neuropathy in the Czech Republic targets chronic nerve damage using autologous mesenchymal stem cells to stimulate regeneration. Czech centers focus on adipose or bone marrow-derived cells to improve blood supply, reduce neuroinflammation, and provide paracrine support to damaged nerve fibers and myelin sheaths.
Bookimed Expert Insight: Czech clinics often collaborate with academic institutions like Charles University, providing access to advanced diagnostics. While costs range from $12,000, verify if the protocol uses IV administration or targeted injections, as direct site application may better address localized peripheral damage.
Patient Consensus: Patients emphasize that this therapy aims for symptom relief rather than a total cure. Many recommend asking for specific data on the cell product, such as exosomes or placental matrix, before beginning treatment.
Private regenerative centers in the Czech Republic, such as Cellthera in Brno and Centrum rizene regenerace in Prague, provide stem cell therapy for neuropathy. These facilities typically use autologous adipose-derived regenerative cells or stromal vascular fraction, as the treatment remains experimental and is not a standard medical practice.
Bookimed Expert Insight: While many clinics offer generic stem cell therapy, the Czech Republic's SAK-accredited facilities often provide higher safety standards for private care. Look for clinics like MY CLINIC that maintain direct billing ties with major international insurers, which suggests a verified level of administrative and medical reliability.
Patient Consensus: Patients often notice minor improvements like reduced burning or better sleep rather than full nerve restoration. It is vital to confirm the specific cell delivery method before starting treatment for autoimmune-related nerve damage.